Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
This webinar is part 2 of a 4 part webinar series. Please visit OCTWebinars.com for information on the full webinar series.
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Carl Zeiss Meditec.
Target Audience:The intended audience for the activity is comprehensive ophthalmologists, retina specialists, ophthalmic technicians and photographers and other healthcare professionals utilizing optical coherence tomography (OCT) instruments involved in the treatment of patients with retinal diseases.
Learning Objectives: Upon successful completion of the activity, participants will be able to:
- Review advances in diagnostic techniques for retinal disorders that can be performed using available OCT hardware and software.
- Examine the evidence for improved treatment precision using OCT-guided therapy.
- Describe the quantification of retinal pathology obtainable using SD-OCT technology and its clinical interpretation.
Contributing Faculty:
Carmen A. Puliafito, MD, MBA
Retina/Vitreous Section Editor
OCULAR SURGERY NEWS
Dean, Keck School of Medicine
Professor of Ophthalmology and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, CA
Philip J. Rosenfeld, MD, PhD
Professor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
Reviewer:
Michael Stewart, MD
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, May 13, 2014 to May 12, 2015.
This course has been awarded 1 JCAHPO credit.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch and listen to the webinar, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or JCAHPO Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Carmen A. Puliafito, MD, MBA
Receipt of Intellectual Property Rights/Patent Holder: Carl Zeiss Meditec
Philip J. Rosenfeld, MD, PhD
Stock Shareholder: Digisight
Consultant/Advisor: Acucela, Alcon, Boehringer Ingelheim, Chengdu Kanghong Biotech, Oraya
Educational grant or research funds: Acucela, Advanced Cell Technology, Alexion, Carl Zeiss Meditec, GlaxoSmithKline
Participated as a member of an advisory panel: Bayer Healthcare Pharmaceuticals, Merck Pharmaceuticals, F. Hoffmann-La Roche Ltd,
External Reviewer reports the following relationship(s):
Michael Stewart, MD
Consulting Fees: Boehringer-Ingelheim, Regeneron
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2014 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicomeded.com